These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

719 related items for PubMed ID: 17114344

  • 1. The tumor suppressor KLF11 mediates a novel mechanism in transforming growth factor beta-induced growth inhibition that is inactivated in pancreatic cancer.
    Buck A, Buchholz M, Wagner M, Adler G, Gress T, Ellenrieder V.
    Mol Cancer Res; 2006 Nov; 4(11):861-72. PubMed ID: 17114344
    [Abstract] [Full Text] [Related]

  • 2. TGFbeta influences Myc, Miz-1 and Smad to control the CDK inhibitor p15INK4b.
    Seoane J, Pouponnot C, Staller P, Schader M, Eilers M, Massagué J.
    Nat Cell Biol; 2001 Apr; 3(4):400-8. PubMed ID: 11283614
    [Abstract] [Full Text] [Related]

  • 3. Inability of transforming growth factor-beta to cause SnoN degradation leads to resistance to transforming growth factor-beta-induced growth arrest in esophageal cancer cells.
    Edmiston JS, Yeudall WA, Chung TD, Lebman DA.
    Cancer Res; 2005 Jun 01; 65(11):4782-8. PubMed ID: 15930298
    [Abstract] [Full Text] [Related]

  • 4. Smad-Sp1 complexes mediate TGFbeta-induced early transcription of oncogenic Smad7 in pancreatic cancer cells.
    Jungert K, Buck A, Buchholz M, Wagner M, Adler G, Gress TM, Ellenrieder V.
    Carcinogenesis; 2006 Dec 01; 27(12):2392-401. PubMed ID: 16714330
    [Abstract] [Full Text] [Related]

  • 5. Rap1 reverses transcriptional repression of TGF-beta type II receptor by a mechanism involving AP-1 in the human pancreatic cancer cell line, UK Pan-1.
    Fralix KD, Zhao S, Venkatasubbarao K, Freeman JW.
    J Cell Physiol; 2003 Jan 01; 194(1):88-99. PubMed ID: 12447993
    [Abstract] [Full Text] [Related]

  • 6. KLF11 mediates a critical mechanism in TGF-beta signaling that is inactivated by Erk-MAPK in pancreatic cancer cells.
    Ellenrieder V, Buck A, Harth A, Jungert K, Buchholz M, Adler G, Urrutia R, Gress TM.
    Gastroenterology; 2004 Aug 01; 127(2):607-20. PubMed ID: 15300592
    [Abstract] [Full Text] [Related]

  • 7. Phosphorylation regulates Myc expression via prolonged activation of the mitogen-activated protein kinase pathway.
    Wang Z, Ge L, Wang M, Carr BI.
    J Cell Physiol; 2006 Jul 01; 208(1):133-40. PubMed ID: 16596619
    [Abstract] [Full Text] [Related]

  • 8. TGFbeta1 represses proliferation of pancreatic carcinoma cells which correlates with Smad4-independent inhibition of ERK activation.
    Giehl K, Seidel B, Gierschik P, Adler G, Menke A.
    Oncogene; 2000 Sep 14; 19(39):4531-41. PubMed ID: 11002426
    [Abstract] [Full Text] [Related]

  • 9. Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors.
    Marampon F, Ciccarelli C, Zani BM.
    Mol Cancer; 2006 Aug 09; 5():31. PubMed ID: 16899113
    [Abstract] [Full Text] [Related]

  • 10. Oncogenic Ras blocks transforming growth factor-beta-induced cell-cycle arrest by degradation of p27 through a MEK/Erk/SKP2-dependent pathway.
    Schepers H, Wierenga AT, Eggen BJ, Vellenga E.
    Exp Hematol; 2005 Jul 09; 33(7):747-57. PubMed ID: 15963850
    [Abstract] [Full Text] [Related]

  • 11. Adenovirus E1A oncoprotein liberates c-Myc activity to promote cell proliferation through abating Bin1 expression via an Rb/E2F1-dependent mechanism.
    Kinney EL, Tanida S, Rodrigue AA, Johnson JK, Tompkins VS, Sakamuro D.
    J Cell Physiol; 2008 Sep 09; 216(3):621-31. PubMed ID: 18348166
    [Abstract] [Full Text] [Related]

  • 12. Transforming growth factor beta signaling via Ras in mesenchymal cells requires p21-activated kinase 2 for extracellular signal-regulated kinase-dependent transcriptional responses.
    Suzuki K, Wilkes MC, Garamszegi N, Edens M, Leof EB.
    Cancer Res; 2007 Apr 15; 67(8):3673-82. PubMed ID: 17440079
    [Abstract] [Full Text] [Related]

  • 13. Inactivation of the Carney complex gene 1 (protein kinase A regulatory subunit 1A) inhibits SMAD3 expression and TGF beta-stimulated apoptosis in adrenocortical cells.
    Ragazzon B, Cazabat L, Rizk-Rabin M, Assie G, Groussin L, Fierrard H, Perlemoine K, Martinez A, Bertherat J.
    Cancer Res; 2009 Sep 15; 69(18):7278-84. PubMed ID: 19738044
    [Abstract] [Full Text] [Related]

  • 14. Cell growth suppression by thanatos-associated protein 11(THAP11) is mediated by transcriptional downregulation of c-Myc.
    Zhu CY, Li CY, Li Y, Zhan YQ, Li YH, Xu CW, Xu WX, Sun HB, Yang XM.
    Cell Death Differ; 2009 Mar 15; 16(3):395-405. PubMed ID: 19008924
    [Abstract] [Full Text] [Related]

  • 15. Smad3 is a key nonredundant mediator of transforming growth factor beta signaling in Nme mouse mammary epithelial cells.
    Dzwonek J, Preobrazhenska O, Cazzola S, Conidi A, Schellens A, van Dinther M, Stubbs A, Klippel A, Huylebroeck D, ten Dijke P, Verschueren K.
    Mol Cancer Res; 2009 Aug 15; 7(8):1342-53. PubMed ID: 19671686
    [Abstract] [Full Text] [Related]

  • 16. Transforming growth factor-beta inhibits telomerase through SMAD3 and E2F transcription factors.
    Lacerte A, Korah J, Roy M, Yang XJ, Lemay S, Lebrun JJ.
    Cell Signal; 2008 Jan 15; 20(1):50-9. PubMed ID: 17881189
    [Abstract] [Full Text] [Related]

  • 17. pRb, Myc and p53 are critically involved in SV40 large T antigen repression of PDGF beta-receptor transcription.
    Uramoto H, Hackzell A, Wetterskog D, Ballági A, Izumi H, Funa K.
    J Cell Sci; 2004 Aug 01; 117(Pt 17):3855-65. PubMed ID: 15265983
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of transforming growth factor beta signaling reduces pancreatic adenocarcinoma growth and invasiveness.
    Gaspar NJ, Li L, Kapoun AM, Medicherla S, Reddy M, Li G, O'Young G, Quon D, Henson M, Damm DL, Muiru GT, Murphy A, Higgins LS, Chakravarty S, Wong DH.
    Mol Pharmacol; 2007 Jul 01; 72(1):152-61. PubMed ID: 17400764
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of the antiproliferative effect of TGFbeta by EGF in primary human ovarian cancer cells.
    Dunfield LD, Nachtigal MW.
    Oncogene; 2003 Jul 24; 22(30):4745-51. PubMed ID: 12879019
    [Abstract] [Full Text] [Related]

  • 20. Smad4 dependency defines two classes of transforming growth factor {beta} (TGF-{beta}) target genes and distinguishes TGF-{beta}-induced epithelial-mesenchymal transition from its antiproliferative and migratory responses.
    Levy L, Hill CS.
    Mol Cell Biol; 2005 Sep 24; 25(18):8108-25. PubMed ID: 16135802
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.